Morgan Landes

Morgan Landes has a diverse work experience in the biopharmaceutical industry. Starting in 2013, Morgan worked at the UC Davis MIND Institute, where they collaborated on research projects related to Alzheimer's disease and Rett Syndrome. In 2014, Morgan joined BioMarin Pharmaceutical Inc., initially as a Coordinator of Process Operations and later taking on roles as a Clinical Project Coordinator, Senior Project Coordinator, and Project Manager. They gained experience in global project management and product development. In 2018, Morgan joined NGM Biopharmaceuticals as a Senior Project Manager, leading drug development projects across different therapeutic areas. In 2020, they transitioned to Allogene Therapeutics as an Associate Director, focusing on program management. Currently, Morgan is working at Annexon Biosciences as the Director of Portfolio Strategy and Operations, a role they started in June 2022. Overall, Morgan has a strong background in project and program management within the biopharmaceutical industry.

Morgan Landes obtained a Bachelor's degree in Psychology from the University of California, Davis in 2013. Morgan Landes does not have any additional certifications in Biohazardous Material Handling.